Literature DB >> 18931050

Bringing down the ROS: a new therapeutic approach for PPHN.

Amy L Firth, Jason X-J Yuan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18931050      PMCID： PMC2654816          DOI： 10.1152/ajplung.90515.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN： 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  15 in total

1.  Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; S R Neish; E Shaffer; S H Abman
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

2.  Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.

Authors:  Philippe Deruelle; Theresa R Grover; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-17       Impact factor: 5.464

3.  Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period.

Authors:  A Mukherjee; T Dombi; B Wittke; R Lalonde
Journal:  Clin Pharmacol Ther       Date:  2008-09-17       Impact factor: 6.875

4.  rhVEGF treatment preserves pulmonary vascular reactivity and structure in an experimental model of pulmonary hypertension in fetal sheep.

Authors:  Theresa R Grover; Thomas A Parker; Neil E Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-04-15       Impact factor: 5.464

5.  Chronic intrauterine pulmonary hypertension decreases calcium-sensitive potassium channel mRNA expression.

Authors:  D N Cornfield; E R Resnik; J M Herron; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

6.  Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Robin H Steinhorn; Melisa Bunderson; Jason Wilham; Satyan Lakshminrusimha; Lisa A Brennan; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-03       Impact factor: 5.464

7.  Contribution of the K(Ca) channel to membrane potential and O2 sensitivity is decreased in an ovine PPHN model.

Authors:  Andrea Olschewski; Zhigang Hong; Bradley C Linden; Valerie A Porter; E Kenneth Weir; David N Cornfield
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11       Impact factor: 5.464

8.  Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide.

Authors:  Stephen Wedgwood; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-11-05       Impact factor: 5.464

9.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J D Roberts; D M Polaner; P Lang; W M Zapol
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

10.  Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity.

Authors:  K A Hanson; J W Ziegler; S D Rybalkin; J W Miller; S H Abman; W R Clarke
Journal:  Am J Physiol       Date:  1998-11
View more
  9 in total

Review 1.  Neonatal pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

Review 2.  Therapeutic approaches using nitric oxide in infants and children.

Authors:  Robin H Steinhorn
Journal:  Free Radic Biol Med       Date:  2011-01-13       Impact factor: 7.376

3.  Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension.

Authors:  Mohamed N Ahmed; Yinzhong Zhang; Champa Codipilly; Nahla Zaghloul; Dhara Patel; Michael Wolin; Edmund J Miller
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

4.  Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Satyan Lakshminrusimha; Kathryn N Farrow; Lyubov Czech; Sylvia F Gugino; Fernando Soares; James A Russell; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-23       Impact factor: 5.464

5.  Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Anna Dikalova; James C Slaughter; M R Kaplowitz; Y Zhang; Judy L Aschner
Journal:  Antioxid Redox Signal       Date:  2013-01-29       Impact factor: 8.401

6.  Oxidative injury is a common consequence of BMPR2 mutations.

Authors:  Kirk L Lane; Megha Talati; Eric Austin; Anna R Hemnes; Jennifer A Johnson; Joshua P Fessel; Tom Blackwell; Ray L Mernaugh; Linda Robinson; Candice Fike; L Jackson Roberts; James West
Journal:  Pulm Circ       Date:  2011       Impact factor: 3.017

7.  Protection of oral hydrogen water as an antioxidant on pulmonary hypertension.

Authors:  Bin He; Yufeng Zhang; Bo Kang; Jian Xiao; Bing Xie; Zhinong Wang
Journal:  Mol Biol Rep       Date:  2013-08-18       Impact factor: 2.316

8.  A process-based review of mouse models of pulmonary hypertension.

Authors:  Mita Das; Joshua Fessel; Haiyang Tang; James West
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

9.  Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy.

Authors:  Adriano R Tonelli; Sarah Haserodt; Metin Aytekin; Raed A Dweik
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.